Clinical Trials Logo
  1. Home
  2. Peripheral Neuropathic Pain
  3. NCT04431778

Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain — E-PENEPA  

Peripheral Neuropathic Pain Clinical Trial

Official title:
Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain

Clinical Trial Summary

Evaluation of the efficacy and tolerance of low doses of ethosuximide in the treatment of peripheral neuropathic pain

Clinical Trial Description

Multicenter, randomized, double-blind, placebo-controlled therapeutic trial evaluating the efficacy and safety of low doses of ethosuximide in neuropathic pain patients. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04431778
Study type Interventional
Source University Hospital, Clermont-Ferrand
Contact Lise Laclautre
Phone +33473754963
Email promo_interne_drci@chu-clermontferrand.fr
Status Recruiting
Phase Phase 2
Start date November 1, 2020
Completion date December 31, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT03733886 - Burst Spinal Cord Stimulation for Neuropathic Pain. N/A
Completed NCT04494815 - A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419 Phase 1/Phase 2
Completed NCT03191136 - Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Volunteers Phase 1
Completed NCT02100046 - Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain. Phase 2
Completed NCT05416931 - ACD440 Gel in Peripheral Neuropathic Pain Phase 2
Completed NCT06234917 - Increasing Sensori-Motor Rhythm Activity by EEG-Neurofeedback to Reduce the Impact of Pain on Daily Functioning N/A
Completed NCT03009500 - Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain Phase 3
Completed NCT01524796 - NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark
Completed NCT02985216 - Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain Phase 3
Recruiting NCT04171453 - Post-marketing Surveillance (PMS) to Observe the Safety and Effectiveness of Lyrica CR Extended Release Tablets
Completed NCT01737294 - Observation of the Use of QUTENZA™ in Standard Clinical Practice N/A
Active, not recruiting NCT05890053 - To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral Neuralgia Phase 3
Completed NCT05219812 - A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain Phase 2
Terminated NCT01293851 - Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage
Completed NCT02209896 - BlueWind Reprieve System for the Treatment of PNP N/A
Completed NCT01240148 - Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy Volunteers Phase 1
Recruiting NCT05817591 - Response Profiles to High-concentration Capsaicin Desensitization in Patients With Peripheral Neuropathic Pain With or Without Allodynia: a Regional Multicenter Prospective Cohort